Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3  (02-2018)

Period of time： 2018年3期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 37

E-ISSN： 2212-4063|17|3

ISSN： 1871-529X

Subject： R3 Basic Medical

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3

Menu

Meet Our Associate Editor

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3 , Vol. 17, Iss. 3, 2018-02 , pp. 153-153

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

An Overview on Cardiovascular Protective Effects of Catechins

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3 , Vol. 17, Iss. 3, 2018-02 , pp. 154-160

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Cardiovascular Events: A Challenge in JAK2-positive Myeloproliferative Neoplasms

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3 , Vol. 17, Iss. 3, 2018-02 , pp. 161-166

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

A Review of the Current Role of Blood Clotting Analyzers in Clinical Practice

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3 , Vol. 17, Iss. 3, 2018-02 , pp. 167-179

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Platelets Structure, Function and Modulator Capacity in Replacement Therapy

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3 , Vol. 17, Iss. 3, 2018-02 , pp. 180-184

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Exosomes in Cholesterol Metabolism and Atherosclerosis

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3 , Vol. 17, Iss. 3, 2018-02 , pp. 185-194

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Atrial Fibrillation Ablation Increases Inflammation-Chemokine Modulation Suppresses Activation of Leukocytes Isolated after Ablation

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3 , Vol. 17, Iss. 3, 2018-02 , pp. 195-204

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Factors Associated with Pulmonary Embolism Recurrence and the Benefits of Long-term Anticoagulant Therapy

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3 , Vol. 17, Iss. 3, 2018-02 , pp. 205-211

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous use of Statins and Atrial Electrical Remodeling in Patients with Cryptogenic Stroke

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3 , Vol. 17, Iss. 3, 2018-02 , pp. 212-215

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Acknowledgements to Reviewers

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders),volume 17,issue 3 , Vol. 17, Iss. 3, 2018-02 , pp. 216-216

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 10 item(s)